Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Adocia    ADOC   FR0011184241

ADOCIA (ADOC)

Real-time Quote. Real-time Tradegate - 02/27 10:31:41 am
19.345 EUR   -3.28%
01/30DJEUROPEAN MORNIN : Corporate Events
2016 ADOCIA : and Lilly announce successful completion of an insulin pump..
2016 ADOCIA : to Participate in Upcoming Investor Conferences
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Adocia
Operates as a clinical-stage biotechnology company

Adocia SA operates as a clinical-stage biotechnology company, which engages in the development of medicines from already approved therapeutic agents.

Its product pipeline includes BioChaperone PDGF, which is in Phase III clinical trials for the treatment of diabetic foot ulcer; BioChaperone insulin that is in Phase I/II clinical trials, as well as in pre-clinical staged for the treatment of diabetes; and Driveln, which is in preclinical stage for the treatment of oncology.

The company was founded by Gérard Soula, OLivier Soula, and Rémi Soula on December 16, 2005 and is headquartered in Lyon, France.



Number of employees : 109 persons.
Sales per Businesses
20142015Delta
EUR (in Million)%EUR (in Million)%
Regenerating Medicine0.704100%36.94100% +5146.59%
Sales per Regions
20142015Delta
EUR (in Million)%EUR (in Million)%
France0.704100%36.94100% +5146.59%
Managers
NameAgeSinceTitle
Gérard Soula PhD, MBA692005Chairman, President & Chief Executive Officer
Valérie Danaguezian-2006Chief Financial Officer & Administrative Director
Olivier Soula PhD, MBA482005Director, Deputy General Manager, Director-R&D
Olivier Martinez PhD, MBA47-Director
Laurent Arthaud55-Director
Dominique Takizawa602011Independent Director
Ekaterina Smirnyagina, PhD502013Independent Director
Rémi Soula PhD, MBA-2005Director-Business Development
David Duracher, PhD--Director-Pharmaceutical Development
Géraldine Favre-Soula--Director-Human Resources Development Department
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 6,847,063 5,249,424 76.7% 3,575 0.1% 76.7%
Shareholders
NameEquities%
Gérard Soula PhD, MBA 898,463 13.1%
BPIFrance Investissement SAS 738,639 10.8%
La Société Hospitalière d'Assurances Mutuelles SA 320,000 4.66%
Olivier Soula PhD, MBA 307,490 4.48%
Rémi Soula PhD, MBA 302,490 4.41%
Aviva Investors France SA 78,416 1.14%
Candriam Belgium SA 72,400 1.06%
ACG Management SAS 67,439 0.98%
CDC Entreprises Valeurs Moyennes SAS 65,732 0.96%
Norges Bank Investment Management 53,708 0.78%
Holdings
NameEquities%Valuation
Adocia (ADOC) 4,1850.061%104,475 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
ADOCIA-67.21%145
AMGEN, INC.19.39%128 555
GILEAD SCIENCES, INC.-2.33%92 143
CELGENE CORPORATION2.14%91 979
REGENERON PHARMACEUTIC..-1.66%38 296
ACTELION LTD22.36%28 792
VERTEX PHARMACEUTICALS..16.83%21 348
GENMAB A/S16.88%11 807
TESARO INC38.98%9 982
EXELIXIS, INC.45.47%6 213
HUALAN BIOLOGICAL ENGI..--.--%4 936
TONGHUA DONGBAO PHARMA..-3.19%4 398
NEUROCRINE BIOSCIENCES..10.39%3 722
BIOCON LTD17.16%3 338
BLUEBIRD BIO INC32.90%3 328
ULTRAGENYX PHARMACEUTI..10.18%3 233
CHINA BIOLOGIC PRODUCT..1.47%2 961
INTERCEPT PHARMACEUTIC..9.70%2 957
BEIJING SL PHARMACEUTI..--.--%2 838
PEPTIDREAM INC-13.32%2 691
KITE PHARMA INC17.31%2 623
Sector Bio Therapeutic Drugs
Adocia : Connections
Institut Mérieux SA
BPIFrance Investissement SAS
FAB Pharma SAS
Lyon Place Financière & Tertiaire
Platine Pharma Services SAS
Alizé Pharma SAS
iSTAR Medical SA
Elsalys Biotech SAS
Capricorn Venture Partners NV
Lyon Pôle Bourse
Company contact information
115 avenue Lacassagne
FR-69003 Lyon
France

Phone : +33 (0)4 72 610 610
Fax : +33 (0)4 72 36 39 67
Internet : http://www.adocia.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- Euronext Paris
- Compartiment B
- CAC All Shares / CAC All-Tradable, CAC Mid Small, CAC PME, CAC Small, EnterNext© PEA-PME 150, Next 150, Next Biotech, PEA, PEA-PME, Tech 40
Stock Exchange Codes
- ISIN Code :  FR0011184241
- Bloomberg Code :  ADOC:FP
- Reuters Code :  ADOC.PA
- Datastream Code :  
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem